Alexandra Olegovna Mariyanats

Alexandra Olegovna Mariyanats

Auto-generated profile, based on publicly available information

Alexandra Olegovna Mariyanats

Institute of Photon Technologies of Federal Scientific Research Centre “Crystallography and Photonics” of Russian Academy of Sciences, 108840 Moscow, Russia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2020 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
TSThomas Später
Thomas Später
AMAleksandra O. Mariyanats
Aleksandra O. Mariyanats
MSMaria A. Syachina
Maria A. Syachina
AMAnton V. Mironov
Anton V. Mironov
ASAlexander G. Savelyev
Alexander G. Savelyev
Vladimir K. PopovVladimir K. Popov
Vladimir K. Popov

3 October 2022 in Molecules
Verified
Journal Article
Open access
PDF file
ETEkaterina Trifanova
Ekaterina Trifanova
MKMaria Aleksandrovna Khvorostina
Maria Aleksandrovna Khvorostina
AMAleksandra O. Mariyanats
Aleksandra O. Mariyanats
ASAnastasia Sochilina
Anastasia Sochilina
MNMaria E. Nikolaeva
Maria E. Nikolaeva
Vladimir K. PopovVladimir K. Popov
Vladimir K. Popov
Modern biocompatible materials of both natural and synthetic origin, in combination with advanced techniques for their processing and functionalization, provide the basis for tissue engineering constructs (TECs) for the effective replacement of specific body defects and guided tissue regeneration. Here we describe TECs fabricated using electrospinning and 3D printing techniques on a base of synthetic (polylactic-co-glycolic acids, PLGA) and natural (collagen, COL, and hyaluronic acid, HA) polymers impregnated with core/shell β-NaYF4:Yb3+,Er3+/NaYF4 upconversion nanoparticles (UCNPs) for in vitro control of the tissue/scaffold interaction. Polymeric structures impregnated with core/shell β-NaYF4:Yb3+,Er3+/NaYF4 nanoparticles were visualized with high optical contrast using laser irradiation at 976 nm. We found that the photoluminescence spectra of impregnated scaffolds differ from the spectrum of free UCNPs that could be used to control the scaffold microenvironment, polymer biodegradation, and cargo release. We proved the absence of UCNP-impregnated scaffold cytotoxicity and demonstrated their high efficiency for cell attachment, proliferation, and colonization. We also modified the COL-based scaffold fabrication technology to increase their tensile strength and structural stability within the living body. The proposed approach is a technological platform for “smart scaffold” development and fabrication based on bioresorbable polymer structures impregnated with UCNPs, providing the desired photoluminescent, biochemical, and mechanical properties for intravital visualization and monitoring of their behavior and tissue/scaffold interaction in real time.

15 June 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
EAEvgeny Nikolaevich Antonov
Evgeny Nikolaevich Antonov
SASofya N. Andreevskaya
Sofya N. Andreevskaya
IBIrina V. Bocharova
Irina V. Bocharova
SBSergei E. Bogorodsky
Sergei E. Bogorodsky
LKLarisa Krotova
Larisa Krotova
Vladimir K. PopovVladimir K. Popov
Vladimir K. Popov
Levofloxacin (LFX) is a highly effective anti-tuberculosis drug with a pronounced bactericidal activity against Mycobacterium tuberculosis (Mtb). In this work, an “organic solvent-free” approach has been used for the development of polylactic-co-glycolic acid (PLGA) microparticles and scaffolds containing LFX at a therapeutically significant concentration, providing for its sustained release. To achieve the target, both nonpolar supercritical carbon dioxide and polar supercritical trifluoromethane have been used. By changing the composition, surface morphology, size, and internal structure of the polymer carriers, one can control the kinetics of the LFX release into phosphate buffered saline solutions and physiological media, providing for its acceptable burst and desirable concentration in the prolonged phase. The biocompatibility and bactericidal efficacy of PLGA/LFX carriers assessed both in vitro (against Mtb phagocytosed by macrophages) and in vivo (against inbred BALB/c mice aerogenically infected with Mtb) demonstrated their anti-tuberculosis activity comparable with that of the standard daily intragastric levofloxacin administration. These results make it possible to consider the developed compositions as a promising candidate for anti-tuberculosis control release formulations providing for the further evaluation of their activity against Mtb and their metabolism in vivo over long periods of tuberculosis infection.

1 September 2025 in EP Europace
Verified
Journal Article
Open access
PSPamela W Sowa
Pamela W Sowa
AMAleksandra Mariyanats
Aleksandra Mariyanats
AKAleksander Kiełbik
Aleksander Kiełbik
ARAnne-Katrin Rohlfing
Anne-Katrin Rohlfing
VNVitalij Novickij
Vitalij Novickij
MGMeinrad Gawaz
Meinrad Gawaz
Aims: Pulsed field ablation (PFA), a cardiac ablation technique using microsecond pulsed electric fields (µsPEF), is widely used in clinical settings, while nanosecond pulsed electric fields (nsPEF) have recently entered clinical trials. Selective ablation of cardiomyocytes over endothelial cells is critical to prevent adverse remodelling, arrhythmias, and thrombosis, yet comparative data on nsPEF vs. µsPEF remain limited. This study investigates the cytotoxic effects and cell death mechanisms induced by nsPEF and µsPEF in cardiac and endothelial cells. Methods and results: Human cardiomyocytes and endothelial cells were exposed to varying electric field intensities with nsPEF and µsPEF using custom-built automated setup to assess permeabilization and cell death. Raman spectroscopy evaluated biochemical changes in cardiomyocytes following electroporation. Ex vivo epicardial ablation was performed on murine hearts using customized electrodes. Maximal cardiomyocyte death occurred 24 h after both pulse types in vitro. Ex vivo, both pulse types produced visible myocardial lesions as early as 1 h post-exposure, with lesion size progressively increasing up to 4 h. Microsecond pulsed electric fields induced significantly greater endothelial damage (ED50: 1.18 kV/cm) than damage to cardiomyocytes (ED50: 1.28 kV/cm), whereas nsPEF affected both cell types equally (ED50: 7.27 kV/cm vs. 7.24 kV/cm). Raman spectroscopy analysis of exposed cells indicated that µsPEF predominantly triggered necrotic or unregulated cell death, while nsPEF exposure was associated with regulated, apoptotic cell death. Conclusion: Pulse duration critically determines electroporation selectivity and downstream death pathways. Nanosecond pulsed electric fields favoured regulated cell death and cardiomyocyte selectivity, highlighting its potential to improve the safety and durability of PFA.

1 May 2020 in Inorganic Materials: Applied Research
Verified
Journal Article
Closed access
PDF file
Andrey Gennad'evich DunaevAndrey Gennad'evich Dunaev
Andrey Gennad'evich Dunaev
AMA. O. Mariyanats
A. O. Mariyanats
MSM. A. Syachina
M. A. Syachina
ETEkaterina Trifanova
Ekaterina Trifanova
Vladimir K. PopovVladimir K. Popov
Vladimir K. Popov
The processes of hydrophilization of the initially hydrophobic surfaces of monolithic disks from D,L-polylactide and polylactoglycolide used to create a variety of tissue-engineered structures based on them are studied. The surface of the studied samples is processed by the method of directed hydrolytic modification, by means of dielectric discharge plasma, by the method of deposition of biocompatible hydrophilic compounds (BHCs) on the surface, or by the method of preliminary introduction of the BHCs into the material of the disk and hydrolytic modification of its surface. Sodium alginate, maltodextrin, and hyaluronic acid are used in experiments as BHCs. A comparative analysis of the contact angles of wetting between the surfaces of the initial disks and treated disks shows that the most hydrophilic surface is the surface of the samples obtained from a powder mixture of aliphatic polyesters with sodium alginate after hydrolytic modification.

27 April 2018 in IOP Conference Series: Materials Science and Engineering
Verified
Conference Paper
Open access
PDF file
Andrey Gennad'evich DunaevAndrey Gennad'evich Dunaev
Andrey Gennad'evich Dunaev
AMA Mariyanac
A Mariyanac
AMAnton Mironov
Anton Mironov
OMO Mironova
O Mironova
Vladimir K. PopovVladimir K. Popov
Vladimir K. Popov
MSM Syachina
M Syachina